Etidocaine Hydrochloride

CAS No. 36637-19-1

Etidocaine Hydrochloride( Duranest | W-19053 | W 19053 | W19053 )

Catalog No. M27981 CAS No. 36637-19-1

Etidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 264 Get Quote
10MG 394 Get Quote
25MG 626 Get Quote
50MG 885 Get Quote
100MG 1188 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Etidocaine Hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Etidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.
  • Description
    Etidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.
  • In Vitro
    IGL-EDC formulations can induce a significant increase in human fibroblasts survival. Cell Viability Assay Cell Line:Human fibroblasts cells Concentration:0, 4, 8, 16, 24 mM Incubation Time:4, 6 and 24 h Result:Showed that cell survival decreased in a (EDC) concentration with time-dependent manner.
  • In Vivo
    Etidocaine (spinal injection, 0.0075%, once) does not show postinjection neurologic deficit. Animal Model:Adult Swiss Webster male mice Dosage:0.0075% Administration:Etidocaine(spinal injection, 0.0075%, once)Result:Did not show postinjection neurologic deficit.
  • Synonyms
    Duranest | W-19053 | W 19053 | W19053
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    D2|5-HT2A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    36637-19-1
  • Formula Weight
    313.89
  • Molecular Formula
    C17H30ClN2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (199.76 mM)
  • SMILES
    Cl.CCC[NH](CC)C(CC)C(=O)Nc1c(C)cccc1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yamazaki S, et al. Comparison of prediction methods for in vivo clearance of (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, a dopamine D2 receptor antagonist, in humans. Drug Metab Dispos. 2004 Apr;32(4):398-404.
molnova catalog
related products
  • Benzonatate

    Benzonatate is an antagonist of sodium channel protein.Na(+) currents are inhibited most potently by a benzonatate fraction containing the 9-ethoxy component.?

  • VX-150

    VX-150 is a highly selective NaV1.8 inhibitor relative to the other sodium channel subtypes (>400-fold).

  • Proparacaine hydroch...

    An irreversible local anesthetic; inhibits pain sensations that is believed to act as an antagonist on voltage-gated sodium channels.